Lonza Group AG
SIX:LONN.SW
Overview | Financials
Company Name | Lonza Group AG |
Symbol | LONN.SW |
Currency | CHF |
Price | 550.8 |
Market Cap | 39,679,909,603 |
Dividend Yield | 0% |
52-week-range | 308.6 - 589.4 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Albert M. Baehny |
Website | https://www.lonza.com |
An error occurred while fetching data.
About Lonza Group AG
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions. The Biologics division engages in the contract development and manufacturing services for biopharmaceuticals. The Small Molecules division
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD